Do popular Weight-Loss drugs weaken bones? new study investigates
NCT ID NCT07428746
Summary
This study aims to see if a common type 2 diabetes medication (GLP-1 RAs like semaglutide) affects muscle strength and bone health in older women. It will observe 20 women over age 65 for 6 months while they take the medication as part of their normal care. Researchers will measure grip strength, balance, and bone density to understand if the treatment helps or harms their muscles and bones.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Grady Memorial Hospital
Atlanta, Georgia, 30303, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.